Veterinary Medicines

RIVAC SHPPi+3LT

Authorised
  • Rabies virus, strain SAD Vnukovo-32, Inactivated
  • Leptospira kirschneri, serovar Grippotyphosa, strain MSLB 1009, Inactivated
  • Leptospira interrogans, serovar Canicola, strain MSLB 1010, Inactivated
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain MSLB 1008, Inactivated
  • Canine parainfluenza virus, strain CPiV-2-Bio 15, Live
  • Canine parvovirus, strain CPV-Bio 12, Live
  • Canine adenovirus 2, strain CAV-2-Bio 13, Live
  • Canine distemper virus, strain CDVU 39, Live
Download as PDF

Product identification

Medicine name:
RIVAC SHPPi+3LT
Active substance:
  • Rabies virus, strain SAD Vnukovo-32, Inactivated
  • Leptospira kirschneri, serovar Grippotyphosa, strain MSLB 1009, Inactivated
  • Leptospira interrogans, serovar Canicola, strain MSLB 1010, Inactivated
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain MSLB 1008, Inactivated
  • Canine parainfluenza virus, strain CPiV-2-Bio 15, Live
  • Canine parvovirus, strain CPV-Bio 12, Live
  • Canine adenovirus 2, strain CAV-2-Bio 13, Live
  • Canine distemper virus, strain CDVU 39, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Rabies virus, strain SAD Vnukovo-32, Inactivated
    2.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Leptospira kirschneri, serovar Grippotyphosa, strain MSLB 1009, Inactivated
    0.02
    unknown
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serovar Canicola, strain MSLB 1010, Inactivated
    0.03
    unknown
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain MSLB 1008, Inactivated
    0.03
    unknown
    /
    1.00
    millilitre(s)
  • Canine parainfluenza virus, strain CPiV-2-Bio 15, Live
    1000.00
    50% tissue culture infectious dose
    /
    1.00
    Dose
  • Canine parvovirus, strain CPV-Bio 12, Live
    3162.00
    50% tissue culture infectious dose
    /
    1.00
    Dose
  • Canine adenovirus 2, strain CAV-2-Bio 13, Live
    31622.00
    50% tissue culture infectious dose
    /
    1.00
    Dose
  • Canine distemper virus, strain CDVU 39, Live
    1000.00
    50% tissue culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AJ06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ecuphar
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • PEI.V.11610.01.1
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 17/10/2023
Download

2612522-parde-20120413.pdf

German (PDF)
Published on: 9/09/2024
Download